BullFrog AI Holdings, Inc. (BFRG): Operating Income

Annual figures by period end, from SEC filings.

-$6.59M

Year ended 2025-12-31

-$6.10M

Trailing 12 months to 2026-06-30

2021-12-31 Operating Income (USD) 2025-12-31

Period ended	Operating Income	Change YoY	Source filing
2025-12-31	-$6.59M	n/m	2026-03-19, From 2025-01-01
2024-12-31	-$7.24M	n/m	2026-03-19, From 2024-01-01
2023-12-31	-$5.37M	n/m	2025-03-14, From 2023-01-01
2022-12-31	-$2.46M	n/m	2024-03-29, From 2022-01-01
2021-12-31	-$555.4K	n/a	2023-04-25, From 2021-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Income	Change YoY
BullFrog AI Holdings, Inc. (BFRG)	2025-12-31	-$6.59M	n/m
Serina Therapeutics, Inc. (SER)	2025-12-31	-$24.02M	n/m
iBio, Inc. (IBIO)	2026-06-30	-$35.14M	n/m
Actinium Pharmaceuticals, Inc. (ATNM)	2025-12-31	-$36.25M	n/m
Incannex Healthcare Inc. (IXHL)	2025-06-30	-$23.79M	n/m
Lisata Therapeutics, Inc. (LSTA)	2025-12-31	-$18.21M	n/m
Silo Pharma, Inc. (SILO)	2025-12-31	-$4.28M	n/m
Clene Inc. (CLNN)	2025-12-31	-$23.08M	n/m
Inovio Pharmaceuticals, Inc. (INO)	2025-12-31	-$86.82M	n/m

Compare BFRG, SER, IBIO, ATNM side by side · Screen every company in Pharmaceutical Preparations ↗